132
Views
13
CrossRef citations to date
0
Altmetric
Liver and Biliary Tract

YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection

, , , , , & show all
Pages 615-622 | Received 31 Aug 2009, Accepted 18 Jan 2010, Published online: 18 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Timo Rath, Martin Roderfeld, Can Güler, Christian Wenzel, Jürgen Graf, Frigga Beitinger, Elke Roeb & Reinhart Zachoval. (2011) YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis. Scandinavian Journal of Gastroenterology 46:11, pages 1369-1380.
Read now

Articles from other publishers (12)

Xiaoting Huang, Jialing Zhuang, Yongqiang Yang, Jiaxin Jian, Wen Ai, Chunyong Liu, Wenzhi Tang, Changyu Jiang, Yongshen He, Lesheng Huang & Se Peng. (2022) Diagnostic Value of Serum Chitinase-3-Like Protein 1 for Liver Fibrosis: A Meta-analysis. BioMed Research International 2022, pages 1-13.
Crossref
Serena Del Turco, Paolo De Simone, Davide Ghinolfi, Melania Gaggini & Giuseppina Basta. (2021) Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients. Arab Journal of Gastroenterology 22:3, pages 187-192.
Crossref
Biao Geng, Jinshun Pan, Ting Zhao, Jie Ji, Chen Zhang, Ying Che, Jing Yang, Hui Shi, Juan Li, Hong Zhou, Xianmin Mu, Che Xu, Chao Wang, Yue Xu, Zheng Liu, Hao Wen & Qiang You. (2018) Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Obiageli Offor, Netanya Utay, David Reynoso, Anoma Somasunderam, Judith Currier & Jordan Lake. (2018) Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy. PLOS ONE 13:5, pages e0196395.
Crossref
Kobra Shiasi, Farbod Talebian, Seyyed Peyman Khamechi, Hassan Nikoueinejad, Mojtaba Sehat, Zohreh Azarbad & Behzad Einollahi. (2017) Evaluation of YKL-40 Serum Level in Patients with Type 1 Diabetes and Its Correlation with Their Metabolic and Renal Conditions. Nephro-Urology Monthly 9:5.
Crossref
Bengu Tatar, Sukran Kose, Emel Pala & Erhan Tatar. (2017) Inflammatory Biomarkers and Liver Histopathology in Non-Uremic and Uremic Chronic Hepatitis C Patients. Acta Medica (Hradec Kralove, Czech Republic) 60:2, pages 71-75.
Crossref
Manuela G. Neuman, Lawrence B. Cohen & Radu M. Nanau. (2016) Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clinical Biochemistry 49:3, pages 302-315.
Crossref
Xiao-Wei Wang, Cheng-Liang Cai, Jing-Ming Xu, Hai Jin & Zhi-Yun Xu. (2014) Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis. Tumor Biology 36:2, pages 901-907.
Crossref
Jian-Ping Zhang, Hai-Xia Yuan, Wen-Tao Kong, Yujun Liu, Zong-Ming Lin, Wen-Ping Wangs & Jian-Ming Guo. (2014) Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma. Tumor Biology 35:12, pages 12131-12137.
Crossref
Hui Tao, Jing-Jing Yang, Kai-Hu Shi, Cheng Huang, Lei Zhang, Xiong-Wen Lv & Jun Li. (2014) The significance of YKL-40 protein in liver fibrosis. Inflammation Research 63:4, pages 249-254.
Crossref
Waqar Ahmad, Bushra Ijaz, Sana Gull, Sultan Asad, Saba Khaliq, Shah Jahan, Muhammad T Sarwar, Humera Kausar, Aleena Sumrin, Imran Shahid & Sajida Hassan. (2011) A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virology Journal 8:1.
Crossref
Nicolai A. Schultz & Julia S. Johansen. (2010) YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?. Cancers 2:3, pages 1453-1491.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.